NCT07828314Completed
Patient Priorities in the Management of Early Oesophageal Cancer: A Discrete Choice Study
Source: ClinicalTrials.gov · Last updated 18 Sept 2026
Brief summary (registry, in English)
Understanding patient priorities is important to providing thorough, individualised care in oesophageal cancer. We aim to use questionnaires to explore what is important to patients when considering radical surgery for oesophageal cancer, and to analyse how patients interpret the risk explained to them during the consent process
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 118 (actual)
- First submitted
- 14 Sept 2026
- Start date
- 6 Aug 2025
- Primary completion date
- 1 Aug 2026
- Lead sponsor
- Portsmouth Hospitals NHS Trust
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07828314
What you commit to
- Study type: Observational
- Participants enrolled: 118
- From 6 Aug 2025 to the primary completion date, 1 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unable or unwilling to give informed consent
Who the study is looking for
- Under care of local MDT for monitoring/surveillance/treatment of Barretts/dysplasia/oesophageal cancer
- able to communicate in English Language
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Portsmouth Hospitals University NHS Trust Coordinator of this site? Confirm its status | Portsmouth | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.